Skip to main content
Hit enter to search or ESC to close
Close Search
Origin Branding
search
Menu
  • Home
  • Services
    • Branding
  • Industries
    • Agricultural
    • Animal Health
    • Consumer
    • Industrial
    • Medical Devices
    • Pharmaceutical
    • Technology
  • Views
  • About
    • The Team
    • Why Choose Us?
  • Contact
  • +44 (0) 208 941 5811
  • search

Novartis – Pagenax

Created for Novartis by Origin – Pagenax (brolucizumab) is is a humanised monoclonal antibody indicated for the treatment of neovascular (wet) Age-related Macular Degeneration (AMD).

Wet macular degeneration is a chronic eye disorder that causes blurred vision or a blind spot in your visual field.

Strong and confident sounding, the name Pagenax, conveys efficacy, innovation and high performance/impact.

  • Previous Project
  • Next Project

United Kingdom

Hampton Court

Bridge House
72 Bridge Road
East Molesey
KT8 9HF

Tel: +44 (0) 20 8941 5811

United States

Birmingham, Michigan

200 Elm Street
Birmingham
Michigan
48009

Tel: +1 248 723 7833

Our Latest Views

  • The Branding Bandwagon – Why Every Business Should Hop On August 26, 2023
  • Logo Love – Deciphering The Symbols Of Big Brands August 26, 2023
  • From Concept To Consumer – The Lifecycle Of Branding August 26, 2023

© 2023 Origin Branding.

  • facebook
  • linkedin
Close Menu
  • Home
  • Services
    • Branding
  • Industries
    • Agricultural
    • Animal Health
    • Consumer
    • Industrial
    • Medical Devices
    • Pharmaceutical
    • Technology
  • Views
  • About
    • The Team
    • Why Choose Us?
  • Contact
  • +44 (0) 208 941 5811